Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19.
Respir Investig. 2021 Nov;59(6):799-803. doi: 10.1016/j.resinv.2021.07.004. Epub 2021 Aug 10.
Respir Investig. 2021.
PMID: 34413006
Free PMC article.